Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Graeber

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Cell|March 20, 2018
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell MalignanciesGang Xiao, Lai N Chan, Lars Klemm, et al.
The Journal of Clinical Investigation|March 10, 2026
The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma ElasticumYijie Wang, Baiming Sun, Feiyang Ma, et al.
Cancer Cell|May 26, 2023
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosisJenna K Minami, Danielle Morrow, Nicholas A Bayley, et al.
Cancer & Metabolism|April 26, 2018
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilitiesMatthew Garrett, Jantzen Sperry, Daniel Braas, et al.
Signal Transduction and Targeted Therapy|April 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Ping Tan, Moe Ishihara, et al.
Cancer Research and Treatment|January 9, 2025
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem CellsMichael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, et al.
Nature Medicine|July 16, 2013
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpointSrividya Swaminathan, Chuanxin Huang, Huimin Geng, et al.
Nature Communications|December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJudith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypesLiang Wang, Bryan A Smith, Nikolas G Balanis, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Cell|March 20, 2018
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell MalignanciesGang Xiao, Lai N Chan, Lars Klemm, et al.
The Journal of Clinical Investigation|March 10, 2026
The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma ElasticumYijie Wang, Baiming Sun, Feiyang Ma, et al.
Cancer Cell|May 26, 2023
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosisJenna K Minami, Danielle Morrow, Nicholas A Bayley, et al.
Cancer & Metabolism|April 26, 2018
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilitiesMatthew Garrett, Jantzen Sperry, Daniel Braas, et al.
Signal Transduction and Targeted Therapy|April 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Ping Tan, Moe Ishihara, et al.
Cancer Research and Treatment|January 9, 2025
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem CellsMichael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, et al.
Nature Medicine|July 16, 2013
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpointSrividya Swaminathan, Chuanxin Huang, Huimin Geng, et al.
Nature Communications|December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJudith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypesLiang Wang, Bryan A Smith, Nikolas G Balanis, et al.
Pageof 16